AbbVie Adds Another Alzheimer’s Prospect With $1.4B Aliada Therapeutics Acquisition
Alzheimer’s disease medicines commercialized in the past two years validated amyloid beta as a drug target, but these antibody therapies ...
Wednesday, March 5, 2025
Tag: 1.4B
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.